188 related articles for article (PubMed ID: 15541411)
1. Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study.
Hajri S; Blum J; Gueddana N; Saadi H; Maazoun L; Chélli H; Dabash R; Winikoff B
Contraception; 2004 Dec; 70(6):487-91. PubMed ID: 15541411
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
3. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
Kapp N; Borgatta L; Ellis SC; Stubblefield P
Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
6. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam.
Ngoc NT; Nhan VQ; Blum J; Mai TT; Durocher JM; Winikoff B
BJOG; 2004 Aug; 111(8):814-9. PubMed ID: 15270929
[TBL] [Abstract][Full Text] [Related]
7. Medical abortion: the Tunisian experience.
Hajri S
Afr J Reprod Health; 2004 Apr; 8(1):63-9. PubMed ID: 15487615
[TBL] [Abstract][Full Text] [Related]
8. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
Shannon C; Wiebe E; Jacot F; Guilbert E; Dunn S; Sheldon WR; Winikoff B
BJOG; 2006 Jun; 113(6):621-8. PubMed ID: 16709204
[TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
10. Study supports the introduction of early medical abortion in Turkey.
Akin A; Kocoglu GO; Akin L
Reprod Health Matters; 2005 Nov; 13(26):101-9. PubMed ID: 16291491
[TBL] [Abstract][Full Text] [Related]
11. Results and lessons learned from a small medical abortion clinical study in Turkey.
Akin A; Blum J; Ozalp S; Onderoğlu L; Kirca U; Bilgili N; Koçoğlu G; Philip N; Winikoff B
Contraception; 2004 Nov; 70(5):401-6. PubMed ID: 15504380
[TBL] [Abstract][Full Text] [Related]
12. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
13. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
Arvidsson C; Hellborg M; Gemzell-Danielsson K
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
[TBL] [Abstract][Full Text] [Related]
15. Mifepristone medical abortion in Albania: results from a pilot clinical research study.
Bracken H; Gliozheni O; Kati K; Manoku N; Moisiu R; Shannon C; Tare V; Tasha I; Winikoff B;
Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):38-46. PubMed ID: 16546815
[TBL] [Abstract][Full Text] [Related]
16. Are two doses of misoprostol after mifepristone for early abortion better than one?
Coyaji K; Krishna U; Ambardekar S; Bracken H; Raote V; Mandlekar A; Winikoff B
BJOG; 2007 Mar; 114(3):271-8. PubMed ID: 17217359
[TBL] [Abstract][Full Text] [Related]
17. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences.
Fielding SL; Edmunds E; Schaff EA
Perspect Sex Reprod Health; 2002; 34(1):34-40. PubMed ID: 11990637
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of home-use of misoprostol in medical abortion.
Fiala C; Winikoff B; Helström L; Hellborg M; Gemzell-Danielsson K
Contraception; 2004 Nov; 70(5):387-92. PubMed ID: 15504378
[TBL] [Abstract][Full Text] [Related]
19. Current medical abortion care.
Creinin MD
Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
[TBL] [Abstract][Full Text] [Related]
20. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
